ABSTRACT
Bone diseases include a wide group of skeletal-related disorders that cause mobility limitations and mortality. In some cases, e.g., in osteosarcoma (OS) and metastatic bone cancer, current treatments are not fully effective, mainly due to low patient compliance and to adverse side effects. To overcome these drawbacks, nanotechnology is currently under study as a potential strategy allowing specific drug release kinetics and enhancing bone regeneration. Polymers, ceramics, semiconductors, metals, and self-assembled molecular complexes are some of the most used nanoscale materials, although in most cases their surface properties need to be tuned by chemical or physical reactions. Among all, scaffolds, nanoparticles (NPs), cements, and hydrogels exhibit more advantages than drawbacks when compared to other nanosystems and are therefore the object of several studies. The aim of this review is to provide information about the current therapies of different bone diseases focusing the attention on new discoveries in the field of targeted delivery systems. The authors hope that this paper could help to pursue further directions about bone targeted nanosystems and their application for bone diseases and bone regeneration.
ABSTRACT
Hydroxyapatite (Ca10(PO4)6(OH)2; HAP) is an essential component of the human bone inorganic phase. At the nanoscale level, nano-HAP (nHAP) presents marked emergent properties differing substantially from those of the bulk counterpart. Interestingly, these properties depend on nanoparticle characteristics. In this study, we investigated the cytotoxicity of rod-shaped crystalline nHAP (10-20 nm × 50-100 nm) in both normal (ARPE-19, BV-2) and tumoral (HepG2, HEp-2, A549 and C6) cells. We found that nHAP was cytotoxic in tumor HEp-2, A549, and C6 cells. Moreover, it induced an expansion of the lysosomal compartment at sublethal concentrations in different cell lines, while lysosomal membrane damage was not detected. In C6 glioma cells, the most sensitive cell line to nHAP, these nanoparticles increased reactive oxygen species (ROS) production and induced DNA damage measured by γ-H2AX phosphorylation. Interestingly, our data also show for the first time that nHAP affects both cell unlimited proliferative capacity and cell migration, two of the major pathways involved in cancer progression. The present results showed the cytotoxic and antiproliferative effects of nHAP and suggest its potential as an alternative agent for glioma therapy.
Subject(s)
Brain Neoplasms/drug therapy , Cell Movement/drug effects , Cell Proliferation/drug effects , Glioma/drug therapy , Hydroxyapatites/pharmacology , Nanoparticles , A549 Cells , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Cell Survival/drug effects , DNA Damage , Glioma/metabolism , Glioma/pathology , Hep G2 Cells , Histones/metabolism , Humans , Lysosomes/drug effects , Lysosomes/metabolism , Lysosomes/pathology , Oxidative Stress , Phosphorylation , Reactive Oxygen Species/metabolism , Signal TransductionABSTRACT
Silicon nanoparticles synthesized by two different methods were surface modified with 3-mercaptopropyltrimethoxysilane. The particles of ~2 nm size exhibit photoluminescence (PL) in the UV-Vis range of the spectrum. The most intense PL band at 430 nm with an emission lifetime of 1-2 ns is attributed to the presence of the surface defects Si-O-Si, generated after anchoring the organic molecule onto the interface. The excitation-emission matrix of this band is essentially independent of the technique of synthesis, crystalline structure, and size of the silicon nanoparticles.
